Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated 1 day ago
Human medicines European public assessment report (EPAR): Optison, perflutren, Date of authorisation: 17/05/1998, Revision: 20, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Optison, perflutren, Date of authorisation...
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 31, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation...
Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 6, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation...
SME info day - navigating EMA support: From development to market authorisation, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 6 November 2026, 09:15 (CET) to 6 November 2026, 15:30 (CET)
1 day ago
SME info day - navigating EMA support: From development to market authorisation...
Human medicines European public assessment report (EPAR): Ozurdex, dexamethasone, Date of authorisation: 26/07/2010, Revision: 22, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Ozurdex, dexamethasone, Date of authorisation...
Human medicines European public assessment report (EPAR): Vyepti, eptinezumab, Date of authorisation: 24/01/2022, Revision: 8, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Vyepti, eptinezumab, Date of authorisation...
ETF recommends updating COVID-19 vaccines to target XFG variant
1 day ago
ETF recommends updating COVID-19 vaccines to target XFG variant
EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2026-2027
1 day ago
EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for...
Need for maximum residue limit (MRL) evaluation for biological substances - Scientific guideline
1 day ago
Need for maximum residue limit (MRL) evaluation for biological substances - Scientific...
List of centrally authorised products with safety-related changes to the product information
1 day ago
List of centrally authorised products with safety-related changes to the product information